IMAX Stock Analysis: Q2 2026 Earnings, Revenue Up 12% While Overhead Fell
In the quarter ended June 30, 2026, IMAX $IMAX grew revenue 12.2% to $102.8 million and cut selling, general and administrative expense by 2.2%. Those two facts in one sentence are the entire investment case. Revenue up, overhead down, gross margin above 61%, and net income up 36.8% to $15.4 million.
The comparison worth drawing is with the exhibitors showing the same films. A theater chain converts a strong box office into revenue by owning or leasing screens, staffing them, and carrying the fixed cost when attendance dips. IMAX licenses its technology and takes a share of the ticket. Same movies, radically different economics, and this quarter shows why.
Company Snapshot
IMAX Corporation designs and licenses premium large-format projection and sound systems, and takes a share of box office from films released in its format. It operates through Technology Products and Services and Content Solutions, with a network spanning 91 countries and a majority-owned subsidiary, IMAX Shanghai, giving it meaningful China exposure.
This analysis covers the Form 10-Q for the quarter ended June 30, 2026, filed July 23, 2026. All figures come from that filing unless attributed otherwise.
The Financial Story
| Q2 2026 | vs Q2 2025 | |
|---|---|---|
| Revenue | $102.8M | +12.2% from $91.7M |
| Gross profit | $62.9M | 61.2% margin |
| SG&A | $34.5M | -2.2% from $35.3M |
| Operating income | $20.8M | |
| Net income | $15.4M | +36.8% from $11.3M |
| Diluted EPS | $0.27 | from $0.21 basic |
The line that matters is SG&A falling while revenue rose. Revenue grew $11.2 million and overhead shrank $0.8 million, which is what operating leverage looks like when it actually shows up rather than being promised. Gross margin of 61.2% is the structural reason: IMAX's incremental revenue carries very little incremental cost, because the expensive part is the technology and the network, both of which already exist.
Net income rose 36.8% on 12.2% revenue growth. That roughly 3x ratio of earnings growth to revenue growth is the whole model in one number.
Two items keep the quarter honest. Restructuring charges were $2.3 million against $0.8 million a year ago, so the SG&A improvement came alongside real restructuring rather than purely from discipline. And research and development was $1.7 million, up slightly from $1.5 million, which is modest for a company whose moat is supposed to be technical.
The seasonality is worth stating plainly because it makes single-quarter annualization misleading. Q1 2026 produced $81.4 million of revenue and $4.2 million of net income. First-half net income is therefore about $19.6 million, not four times the second quarter. IMAX earns disproportionately in quarters with a strong blockbuster slate.
The balance sheet is comfortable but not pristine. Cash is $159.9 million against $243.8 million of convertible notes and other borrowings, so IMAX carries roughly $84 million of net debt. Total assets are $917.9 million against $467.5 million of liabilities, leaving $355.9 million of shareholders' equity, or $449.7 million including the non-controlling interest in the Shanghai subsidiary.
Compare that to an exhibitor's structure and the contrast is stark. IMAX has modest net debt and no obligation to keep the lights on in thousands of auditoriums. Its costs do not scale with attendance the way a lease and a payroll do. When box office is strong, the money reaches the bottom line; when it is weak, IMAX shrinks rather than bleeds.
Valuation
Market capitalization sits near $2.16 billion (companiesmarketcap.com, July 2026). Add roughly $84 million of net debt and enterprise value is about $2.24 billion.
Against roughly $400 million of annualized revenue, that is around 5.6x sales. For a licensing model with 61% gross margins that multiple is defensible, but it is not cheap, and it is important to be clear about what it implies: the market has already priced the operating leverage. IMAX is not a mispriced asset trading on depressed earnings. It is a good business trading at a multiple that assumes the good quarters continue.
| Scenario | Revenue path | Net margin | Implied EV | Implied per share |
|---|---|---|---|---|
| Bear | flat ~$400M, weak slate | 8% (~$32M) | ~$1.3B | ~$21 |
| Base | ~$430M, normal slate | 12% (~$52M) | ~$2.1B | ~$36 |
| Bull | ~$480M, strong slate | 15% (~$72M) | ~$2.9B | ~$50 |
Assumptions, stated plainly: a 40x EV to net income multiple, which is where premium-margin licensing businesses with network effects tend to trade, net debt held at $84 million, and about 56.6 million diluted shares. The multiple is the aggressive assumption; at 25x the base case falls to roughly $22 per share. Implied values under stated assumptions. Not price targets, not investment advice.
Risks
The dominant risk is one IMAX does not control: the film slate. Its revenue is a function of how many people want to see the movies that studios release in a given quarter, and the company has no influence over what gets greenlit or when it ships. A thin year is a thin year.
Second, China. IMAX Shanghai is a majority-owned subsidiary and the filing calls out risks tied to the company's significant presence there and its continued expansion. Box office in 91 countries also means currency exposure between local currencies and the dollar.
Third, the multiple itself is the risk. At roughly 5.6x sales, a couple of soft quarters compress the valuation faster than they compress the earnings. That is the opposite of the RGP or AMC situation, where a low multiple already prices in trouble.
Fourth, restructuring charges tripling year over year suggests the cost improvement required action rather than arriving for free, and there is a limit to how long overhead can fall while revenue grows.
The Bottom Line
IMAX is the clean version of a business model people usually only describe in theory: revenue that grows while overhead falls, because the expensive assets are already built and someone else operates the venues.
The thing to watch is the SG&A line against revenue. This quarter it moved the right way on both sides, which is what a 36.8% earnings gain on 12.2% revenue growth requires. If revenue keeps growing while overhead creeps back up, the multiple has a long way to fall. If the pattern in this quarter holds through a normal slate, the market's price is closer to right than it looks.
Every figure in this analysis was pulled directly from IMAX's SEC filings via the RoboSystems shared data repository. Run your own queries on any public company at robosystems.ai.
This is not investment advice. No price targets. Implied values are illustrative under the stated assumptions.